Market Access Medicare weight loss drug pilot on ice as insurers decline to contribute Pharmaceutical TechnologyThe US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.Market AccessMetabolic & GLP-1Read full story pharminent April 22, 2026 (Last updated: April 23, 2026) Pharmaceutical Technology The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027. Market AccessMetabolic & GLP-1Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Revolution drug shows promise in early pancreatic cancerNext: FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars Related Stories Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026 Market Access UK, pharma industry pilot rapid access routes for medicines pharminent July 5, 2026 Market Access Medicare GLP-1 Bridge Launches July 1 With $50 Copays pharminent July 3, 2026
